Results 61 to 70 of about 2,457,234 (292)

New generation of current-to-voltage converters for measuring photo-signals

open access: yesТехнологія та конструювання в електронній апаратурі, 2008
Technical specifications are presented for a new generation of current-to-voltage converters, which feature a low input resistance (
V. K. Butenko   +4 more
doaj  

Current status of Pb-free PSCs and infer the highest achievable PCE via numerical modeling, and optimization of novel structure FAMASnGeI3 based PSCs

open access: yesMaterials Research Express
In this study, we have extensively investigated an eco-friendly perovskite-based solar cell via a theoretical approach and numerical simulation. For that purpose, firstly, we have conducted a brief literature review to decipher the status of Pb-free ...
Hairul Mardiah Hamzah   +6 more
doaj   +1 more source

Solar constraints on asymmetric dark matter

open access: yes, 2012
The dark matter content of the Universe is likely to be a mixture of matter and antimatter, perhaps comparable to the measured asymmetric mixture of baryons and antibaryons.
Lopes, Ilidio, Silk, Joseph
core   +2 more sources

Dark Energy Scaling from Dark Matter to Acceleration [PDF]

open access: yes, 2014
The dark sector of the Universe need not be completely separable into distinct dark matter and dark energy components. We consider a model of early dark energy in which the dark energy mimics a dark matter component in both evolution and perturbations at
Bielefeld, Jannis   +2 more
core   +3 more sources

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Current status of inert Higgs dark matter with dark fermions

open access: yesPhysical Review D
The precision measurements of the muon magnetic moment and the W boson mass have sparked interest in the potential deviations from standard model (SM) predictions. While it may be premature to attribute any excesses in these precision measurements to new physics, they do offer a valuable indication of potential directions for physics beyond the SM ...
Yi-Zhong Fan   +6 more
openaire   +2 more sources

The annihilation cross section of dark matter which is driven by scalar unparticle

open access: yes, 2013
We analyze the annihilation cross section of dark matter which interacts with the standard model sector over the scalar unparticle propagator. We observe that the annihilation cross section of dark matter pair is sensitive to the dark matter mass and the
Iltan, E. O.
core   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Dark Current Evolution in Irradiated MWIR HgCdTe Photodiodes

open access: yesJournal of Electronic Materials, 2023
HgCdTe detectors are a key technology for space-based infrared imagery. Radiation in the space environment afects the performance of these detectors. Gamma and protons irradiation are performed in order to assess the impact of total ionising dose and displacement damage dose on the dark current of mid-wavelength infrared HgCdTe photodiodes.
Dinand, S   +7 more
openaire   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy